Jane Street Group, LLC Protalix Bio Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 16, 2021	SELL	$1.31 - $1.87 $67,596 - $96,492	-51,600 Reduced 30.14%	119,600 $159,000
Q2 2021 Aug 16, 2021	BUY	$1.86 - $6.22 $260,586 - $871,422	140,100 Added 450.48%	171,200 $327,000
Q1 2021 May 18, 2021	BUY	$3.58 - $6.45 $111,338 - $200,595	31,100 New	31,100 $139,000

3.58M

61.1K

36.2K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $89.6M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.